FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2001022740> ?p ?o ?g. }

• W2001022740 endingPage "57" @default.
• W2001022740 startingPage "53" @default.
• W2001022740 abstract "Microglia are the prime effector cells involved in immune and inflammatory responses in the central nervous system (CNS). In pathological conditions, microglia are activated to restore CNS homeostasis. However, chronic microglial activation endangers neuronal survival through the release of various toxic proinflammatory molecules. Thus, negative regulators of microglial activation have been identified as potential therapeutic candidates in many neurological diseases. A number of selenium-containing compounds show antioxidant activity. In this study, we investigated 2-amino-1,3-selenazole derivatives with regard to anti-inflammatory activity or inhibitory effects on microglial activation. Among 26 derivatives of 2-amino-1,3-selenazole and bis-(2-amino-5-selenazoyl) ketones, we observed that 5-chloroacetyl-2-piperidino-1,3-selenazole (CS1) and 5-chloroacetyl-2-morpholino-1,3-selenazole (CS2) strongly inhibited lipopolysaccharide (LPS)-induced nitric oxide (NO) release from BV2 microglial cells. In rat primary cultured microglia, CS1 and CS2 significantly reduced LPS-induced production of NO, tumor necrosis factor (TNF)-α, and prostaglandin E2. Real-time reverse transcription-polymerase chain reaction analysis revealed that the pretreatment of primary microglial cells with CS1 and CS2 attenuated LPS-induced mRNA expression for inducible NO synthase, TNF-α, interleukin-1β, and cyclooxygenase-2. In addition, CS1 and CS2 suppressed LPS-induced activation of nuclear factor-κB and Akt. These results suggest that CS1 and CS2 may provide neuroprotection by suppressing the proinflammatory pathway in activated microglia." @default.
• W2001022740 created "2016-06-24" @default.
• W2001022740 creator A5010287436 @default.
• W2001022740 creator A5034879383 @default.
• W2001022740 creator A5078379907 @default.
• W2001022740 date "2008-07-01" @default.
• W2001022740 modified "2023-10-12" @default.
• W2001022740 title "5-Chloroacetyl-2-amino-1,3-selenazoles attenuate microglial inflammatory responses through NF-κB inhibition" @default.
• W2001022740 cites W1617532721 @default.
• W2001022740 cites W1915946375 @default.
• W2001022740 cites W1969995290 @default.
• W2001022740 cites W1978791886 @default.
• W2001022740 cites W1994870126 @default.
• W2001022740 cites W2013237027 @default.
• W2001022740 cites W2014030835 @default.
• W2001022740 cites W2014781588 @default.
• W2001022740 cites W2039968218 @default.
• W2001022740 cites W2052064431 @default.
• W2001022740 cites W2055179260 @default.
• W2001022740 cites W2059994807 @default.
• W2001022740 cites W2062194308 @default.
• W2001022740 cites W2070662350 @default.
• W2001022740 cites W2072732729 @default.
• W2001022740 cites W2074753416 @default.
• W2001022740 cites W2078042930 @default.
• W2001022740 cites W2079733392 @default.
• W2001022740 cites W2094305716 @default.
• W2001022740 cites W2099249565 @default.
• W2001022740 cites W2120545807 @default.
• W2001022740 cites W2137850881 @default.
• W2001022740 cites W2151283331 @default.
• W2001022740 cites W2160943316 @default.
• W2001022740 cites W2950255050 @default.
• W2001022740 doi "https://doi.org/10.1016/j.ejphar.2008.03.034" @default.
• W2001022740 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18538761" @default.
• W2001022740 hasPublicationYear "2008" @default.
• W2001022740 type Work @default.
• W2001022740 sameAs 2001022740 @default.
• W2001022740 citedByCount "52" @default.
• W2001022740 countsByYear W20010227402012 @default.
• W2001022740 countsByYear W20010227402013 @default.
• W2001022740 countsByYear W20010227402014 @default.
• W2001022740 countsByYear W20010227402015 @default.
• W2001022740 countsByYear W20010227402016 @default.
• W2001022740 countsByYear W20010227402017 @default.
• W2001022740 countsByYear W20010227402018 @default.
• W2001022740 countsByYear W20010227402019 @default.
• W2001022740 countsByYear W20010227402020 @default.
• W2001022740 countsByYear W20010227402021 @default.
• W2001022740 countsByYear W20010227402022 @default.
• W2001022740 crossrefType "journal-article" @default.
• W2001022740 hasAuthorship W2001022740A5010287436 @default.
• W2001022740 hasAuthorship W2001022740A5034879383 @default.
• W2001022740 hasAuthorship W2001022740A5078379907 @default.
• W2001022740 hasConcept C134018914 @default.
• W2001022740 hasConcept C164027704 @default.
• W2001022740 hasConcept C17991360 @default.
• W2001022740 hasConcept C185592680 @default.
• W2001022740 hasConcept C203014093 @default.
• W2001022740 hasConcept C25498285 @default.
• W2001022740 hasConcept C2776914184 @default.
• W2001022740 hasConcept C2777622882 @default.
• W2001022740 hasConcept C2777730290 @default.
• W2001022740 hasConcept C2777956040 @default.
• W2001022740 hasConcept C2778754761 @default.
• W2001022740 hasConcept C2779830541 @default.
• W2001022740 hasConcept C519581460 @default.
• W2001022740 hasConcept C55493867 @default.
• W2001022740 hasConcept C86803240 @default.
• W2001022740 hasConcept C87753298 @default.
• W2001022740 hasConcept C98274493 @default.
• W2001022740 hasConceptScore W2001022740C134018914 @default.
• W2001022740 hasConceptScore W2001022740C164027704 @default.
• W2001022740 hasConceptScore W2001022740C17991360 @default.
• W2001022740 hasConceptScore W2001022740C185592680 @default.
• W2001022740 hasConceptScore W2001022740C203014093 @default.
• W2001022740 hasConceptScore W2001022740C25498285 @default.
• W2001022740 hasConceptScore W2001022740C2776914184 @default.
• W2001022740 hasConceptScore W2001022740C2777622882 @default.
• W2001022740 hasConceptScore W2001022740C2777730290 @default.
• W2001022740 hasConceptScore W2001022740C2777956040 @default.
• W2001022740 hasConceptScore W2001022740C2778754761 @default.
• W2001022740 hasConceptScore W2001022740C2779830541 @default.
• W2001022740 hasConceptScore W2001022740C519581460 @default.
• W2001022740 hasConceptScore W2001022740C55493867 @default.
• W2001022740 hasConceptScore W2001022740C86803240 @default.
• W2001022740 hasConceptScore W2001022740C87753298 @default.
• W2001022740 hasConceptScore W2001022740C98274493 @default.
• W2001022740 hasIssue "1-3" @default.
• W2001022740 hasLocation W20010227401 @default.
• W2001022740 hasLocation W20010227402 @default.
• W2001022740 hasOpenAccess W2001022740 @default.
• W2001022740 hasPrimaryLocation W20010227401 @default.
• W2001022740 hasRelatedWork W2140542329 @default.
• W2001022740 hasRelatedWork W2803817550 @default.
• W2001022740 hasRelatedWork W2804482952 @default.
• W2001022740 hasRelatedWork W2807379694 @default.
• W2001022740 hasRelatedWork W2965172925 @default.

• next